Why the study?
Platelet-leukocyte complexes increase after acute myocardial infarction and predict adverse outcomes, prompting questions regarding their pathomechanistic relevance and therapeutic potential in myocardial ischemia and reperfusion injury.
Does preventing platelet-leukocyte complex formation reduce myocardial ischemia and reperfusion injury in mice?
Does preventing platelet-leukocyte complex formation reduce myocardial ischemia and reperfusion injury in mice?
Platelet-leukocyte complex formation does not influence myocardial ischemia and reperfusion injury, suggesting it is not a viable therapeutic target in myocardial infarction.
PLC dispensable for IR injury and leukocyte recruitment; leaves open alternative therapeutic targets in human MI.
AIMS: P-selectin is an activatable adhesion molecule on platelets promoting platelet aggregation, and platelet-leukocyte complex (PLC) formation. Increased numbers of PLC are circulating in the blood of patients shortly after acute myocardial infarction and predict adverse outcomes. These correlations led to speculations about whether PLC may represent novel therapeutic targets. We therefore set out to elucidate the pathomechanistic relevance of PLC in myocardial ischemia and reperfusion injury. METHODS AND RESULTS: By generating P-selectin deficient bone marrow chimeric mice, the post-myocardial infarction surge in PLC numbers in blood was prevented. Yet, intravital microscopy, flow cytometry and immunohistochemical staining, echocardiography, and gene expression profiling showed unequivocally that leukocyte adhesion to the vessel wall, leukocyte infiltration, and myocardial damage post-infarction were not altered in response to the lack in PLC. CONCLUSION: We conclude that myocardial infarction associated sterile inflammation triggers PLC formation, reminiscent of conserved immunothrombotic responses, but without PLC influencing myocardial ischemia and reperfusion injury in return. Our experimental data do not support a therapeutic concept of selectively targeting PLC formation in myocardial infarction.
No takes yet. Share an insight, caveat, or question.
Starz et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: